Running to train for a marathon cuts heart disease risk and boosts heart structure and function, according to a study led by cardiologist Aaron Baggish, MD.
Mass General researcher and donor Joel Habener, MD, advances diabetes research and the careers of promising young investigators.
The scientists at the Massachusetts Alzheimer’s Disease Research Center are pioneering a unique new gene therapy that could stop the disease in its tracks.
A team from the MGH Center for Assessment Technology and Continuous Health (CATCH) has launched an iPhone app created to help study type 2 diabetes.
The Making Tracks for Celiacs Walk/Runs have raised more than $2.5 million for celiac disease research and national and local awareness initiatives.
When it comes to food, the physician-researcher is passionate about an ingredient that has fueled both his career and a national dietary fervor: gluten.
Neurologist Anne Louise Oaklander, MD, PhD, of Mass General, uses her research to identify neurological causes of mysterious symptoms, so patients can receive better treatments.
New MGH research finds that neither breastfeeding nor delayed introduction of gluten-containing foods provide significant protection against celiac disease.
At Mass General, last summer’s Ice Bucket Challenge has generated fresh opportunities for ALS researchers to develop new treatments and search for a cure.
Powered by a risk-taking strategy, the Cure Alzheimer’s Fund employs venture capital principles to spur Alzheimer’s disease research into a new era at MGH and beyond.